Ledger.Open graph →
SEC Form D · filed October 3, 2019

Paragon Biosciences Emalex Capital, Inc

Offering
$37.4M
Sold
$37.4M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
NORTHBROOK, IL
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Patrick Morris · Northbrook, ILExec · DirectorKevin Chavers · New York, NYDirectorSophie Pibouin · COLUMBUS, OHExec · DirectorDarien Parhad · Northbrook, ILExecTom Marrel · Scottsdale, AZExecRicardo Lombardi · New York, NYDirectorRussell Middleton · San Francisco, CADirectorAntonio J. Gracias · Chicago, ILDirectorTanner Beckstrand · Bluffdale, UTDirectorJeffrey Aronin · Northbrook, ILDirectorVishal Makhijani · San Francisco, CAExecGeorge A. Kahle, Iii · Vero Beach, FLExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗